尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Waheed Nadia. Director active across 2 companies, notably Ocular Therapeutix, INC. In total, 7 disclosures have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €180k. History available since 1 June 2024. The latest transaction was filed on 20 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Waheed Nadia is Chief Medical Officer at OCULAR THERAPEUTIX, INC and Ocular Therapeutix, INC, the two entities named in the filings. Across 7 filings in total, the 7 sampled filings cover the period from 2024-06-04 to 2026-02-24, with 0 in buys and 180358 in sells, and the stated transaction nature is Attribution.